Skip to content

Comprehensive Evaluation of Visual Quality for Different Optical Designs of Intraocular Lenses: A Combined Indicator System Based on Defocus Curve, Wavefront Aberration, and Contrast Sensitivity

Comprehensive Evaluation of Visual Quality for Different Optical Designs of Intraocular Lenses: A Combined Indicator System Based on Defocus Curve, Wavefront Aberration, and Contrast Sensitivity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123147
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-22
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

A certain type of artificial lens:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 45 years, planned to undergo micro-incision phacoemulsification cataract extraction combined with IOL implantation; 2. The preoperative fundus can be directly observed and the imaging can be evaluated, and it is expected that the postoperative visual function will not be dominated by the fundus disease; 3. Corneal endothelial cell count >= 2000 cells/mm^2; 4. Corneal topography is regular, corneal astigmatism <= 1.00 D, and there is no keratoconus/suspicious manifestations; 5. Willing and able to complete the 1-month postoperative follow-up on time; 6. Signed the informed consent form

Exclusion criteria

Exclusion criteria: 1.Presence of any ocular disease that may affect postoperative visual quality or its assessment, including but not limited to: corneal pathologies, glaucoma, chronic or recurrent uveitis, macular diseases, retinal vascular diseases, optic neuropathies, amblyopia, history of ocular trauma, or previous intraocular surgery. 2.Presence of systemic diseases that may affect IOL stability, such as Marfan syndrome, uncontrolled diabetes mellitus, autoimmune diseases, etc.?; 3.Occurrence of intraoperative or postoperative complications that severely affect visual quality, such as posterior capsular rupture, IOL suspension, corneal endothelial decompensation, or persistent cystoid macular edema.?; 4.Inability to cooperate with and complete all required visual function examinations.?;

Design outcomes

Primary

MeasureTime frame
Whole-eye wavefront aberrations (e.g., total HOAs, spherical aberration, coma) and MTF measured under scotopic conditions at various pupil diameters (3mm, 5mm) using the OPD-Scan III.;The BWFOM (Bilateral Wavefront Optical Metrology) integrated host-guest dual-eye wavefront optometry instrument measures the defocus curve and wavefront aberration of the eye being examined.;The AULCSF measured by qCSF;CSF visual acuity;The contrast sensitivity (CS) at spatial frequencies of 1, 1.5, 3, 6, 12, and 18 cpd;

Secondary

MeasureTime frame
Measured monocular UDVA, CDVA, UIVA (at 80 cm), UNVA (at 40 cm), and subjective refraction.;The postoperative tilt angle (°) and eccentricity (mm) measured by CASIA2 swept-source anterior segment optical coherence tomography;Catquest-9SF subjective visual quality questionnaire score;

Countries

China

Contacts

Public ContactChang Pingjun

Wenzhou Medical University Affiliated Eye and Vision Hospital

364669877@qq.com+86 18868410303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026